Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant

antimicrobial susceptibility antimicrobial therapy carbapenem-resistant Acinetobacter baumannii cefiderocol mechanisms of resistance sulbactam-durlobactam

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
14 Dec 2023
Historique:
received: 24 11 2023
revised: 11 12 2023
accepted: 12 12 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: epublish

Résumé

Infections caused by carbapenem-resistant

Identifiants

pubmed: 38136764
pii: antibiotics12121729
doi: 10.3390/antibiotics12121729
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Italian Ministry of University and Research (MUR)
ID : P2022YCH8R

Auteurs

Arta Karruli (A)

Department of Precision Medicine, University of Campania "L. Vanvitelli", 80138 Naples, Italy.

Antonella Migliaccio (A)

Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.

Spyros Pournaras (S)

Clinical Microbiology Laboratory, Medical School, "Attikon" University General Hospital, National and Kapodistrian University of Athens, 1 Rimini Street, 12462 Athens, Greece.

Emanuele Durante-Mangoni (E)

Department of Precision Medicine, University of Campania "L. Vanvitelli", 80138 Naples, Italy.

Raffaele Zarrilli (R)

Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.

Classifications MeSH